EU Approves New Twice-Yearly HIV Prevention Drug

The EU has approved a new shot, lenacapavir, that prevents HIV.

This shot only needs to be given twice a year.

Studies show it works very well, nearly stopping HIV from spreading.

The World Health Organization also supports its use.

Other HIV prevention methods include daily pills and injections given every two months.

Lenacapavir's longer protection may appeal to those who prefer fewer clinic visits.

However, some worry that the drug won't be available everywhere, especially in areas with growing HIV rates, despite the drugmaker's plans for cheaper versions in many countries.